TAK-024 is a platelet inhibitor used for preventing arterial thrombus formation; it inhibits ex vivo ADP-induced platelet aggregation and demonstrates dose-dependent antiplatelet effects in vivo; it is effective in models of carotid thrombosis induced by balloon injury in guinea pigs.